B型尿钠肽前体N末端对全身性感染患者预后的评估价值  

B-type Natriuretic Peptide Precursor N-terminal to Assess the Value of Systemic Infection and the Prognosis of Patients

作　　者：朱秋玲[1] 蒋兰茂[1] 苏学飞[1] 陈广新[1] 

机构地区：[1]广州市花都区人民医院,广东广州510800

出　　处：《中国医药指南》2012年第33期71-72,共2页Guide of China Medicine

摘　　要：目的研究分析B型尿钠肽前体N末端(NT-proBNP)对全身感染患者预后的评估价值。方法将我院2008年2月至2011年10月收治的全身感染患者41例作为研究对象。根据患者的预后分为存活组与死亡组,观察对比患者入院时的NT-proBNP检测结果。结果经统计分析,死亡组患者入院时NT-proBNP浓度明显高于存活组患者,P<0.05;死亡组患者经过3d的治疗后NT-proBNP值仍高于对照组,P<0.05。结论 B型尿钠肽前体N末端对全身性感染患者预后有一定的评估价值,其浓度越高,表示患者严重程度越重。Objective To study the assessed value of analysis of the B-type natriuretic peptide precursor N-terminal（NT-proBNP） prognosis of patients with systemic infection.Methods Systemic infection admitted to hospital in 2008 February to October 2011 41 patients as research subjects.According to the prognosis of the patients are divided into the survival group and death group,observed in contrast to patients on admission NT-proBNP test results.Results After statistical analysis,NT-proBNP concentration in patients admitted to hospital when the death group was significantly higher than survival of patients,P0.05;death in patients after 3 days after treatment,NT-proBNP values are still higher than that in the control group（P0.05）.Conclusion Btype natriuretic peptide precursor N-terminal infection in patients with systemic prognosis of the appraised value of the higher concentration,indicating that patients with the severity of the heavier.

关 键 词：B型尿钠肽前体N末端 全身性感染 NT-PROBNP 

分 类 号：R631[医药卫生—外科学]